These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 23679262

  • 1. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
    Li JY, Zhang Y, Zhang WH, Jia S, Kang Y, Tian R.
    Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
    [Abstract] [Full Text] [Related]

  • 2. Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers.
    Li JY, Zhang Y, Zhang WH, Jia S, Kang Y, Zhu XY.
    Asian Pac J Cancer Prev; 2012; 13(5):1901-6. PubMed ID: 22901144
    [Abstract] [Full Text] [Related]

  • 3. Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.
    Cascione L, Gasparini P, Lovat F, Carasi S, Pulvirenti A, Ferro A, Alder H, He G, Vecchione A, Croce CM, Shapiro CL, Huebner K.
    PLoS One; 2013; 8(2):e55910. PubMed ID: 23405235
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM, Kim HJ, Kim EJ, Chung YR, Yun S, Seo AN, Lee HJ, Park SY.
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G, Yao L, Zhang J, Li X, Dang S, Zeng K, Zhou Y, Gao F.
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [Abstract] [Full Text] [Related]

  • 8. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP, Tang S, Sun WJ, Gao WM, Wang M, Su XL.
    Asian Pac J Cancer Prev; 2014 Jun; 15(20):8893-900. PubMed ID: 25374225
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
    Zheng M, Sun X, Li Y, Zuo W.
    Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
    [Abstract] [Full Text] [Related]

  • 13. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer.
    Chen CN, Chang CC, Su TE, Hsu WM, Jeng YM, Ho MC, Hsieh FJ, Lee PH, Kuo ML, Lee H, Chang KJ.
    Ann Surg Oncol; 2009 Feb; 16(2):524-33. PubMed ID: 19050968
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.
    Dai H, Gallagher D, Schmitt S, Pessetto ZY, Fan F, Godwin AK, Tawfik O.
    Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.